Omada Health, Inc. (OMDA): Cash & Equivalents
$222.04M
As of 2025-12-31
$243.15M
As of 2026-09-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $222.04M | +190.7% | 2026-03-06, Balance as of period end |
| 2024-12-31 | $76.39M | n/a | 2026-03-06, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | 2025-12-31 | $222.04M | +190.7% |
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $105.00M | +23.2% |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $35.57M | -14.0% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $97.89M | +52.6% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $248.64M | +60.9% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | $25.01M | -35.6% |
| Privia Health Group, Inc. (PRVA) | 2025-12-31 | $479.69M | -2.3% |
| Vsee Health, Inc. (VSEE) | 2025-12-31 | $5.27M | n/m |
| Agape ATP Corp (ATPC) | 2025-12-31 | $140.1K | -93.1% |
Compare OMDA, WGS, USPH, INNV side by side · Screen every company in Services-Health Services ↗